Gonadal Toxicity in Women With Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
R-ABVD vs ABVD-RT in Early Stage Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE3
124I-FIAU Imaging in EBV and KSHV Associated Cancers
- Status
- COMPLETED
- Phase
- NA
Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Early Chemotherapy Intensification in Interim-Positron Emission Tomography (PET) Positive Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- N/A
Proton Therapy for Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- NA
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Methionine PET/CT Studies In Patients With Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL)
- Status
- UNKNOWN
- Phase
- PHASE2
HD16 for Early Stage Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of XmAb®2513 to Treat Hodgkin Lymphoma or Anaplastic Large Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)
- Status
- UNKNOWN
- Phase
- PHASE2
T-Reg Cell Kinetics, Stem Cell Transplant, REGALE
- Status
- TERMINATED
- Phase
- NA
Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
MGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin or Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD
- Status
- COMPLETED
- Phase
- PHASE2